Home › Myelodysplastic Syndromes › Washington › Renton
Myelodysplastic Syndromes clinical trials in Renton, WA
3 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Renton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
- Epic Care Emeryville, Issaquah · 9 mi away
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Swedish Cancer Institute-Issaquah, Issaquah · 9 mi away
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Swedish Cancer Institute-Issaquah, Issaquah · 9 mi away
About Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.
More about Myelodysplastic Syndromes on MedlinePlus
Myelodysplastic Syndromes trials in other cities
- Houston, TX43 studies
- Baldwin Park, CA27 studies
- New York City, NY22 studies
- Seattle, WA21 studies
- Boston, MA20 studies
- Tampa, FL20 studies
- Washington, DC19 studies
- Miami, FL17 studies
- Durham, NC14 studies
- Columbus, OH14 studies
- Atlanta, GA13 studies
- Chicago, IL13 studies
Other studies in Renton
- Non-Small Cell Lung Cancer9 studies
- Colorectal Cancer8 studies
- Obesity7 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Overweight6 studies
- Type 2 Diabetes6 studies
- Prostate Cancer5 studies
- Melanoma4 studies
- Colon Cancer4 studies
- Metastatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.